Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA Receptor
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Two metabolites of the steroid hormones progesterone and deoxycorticosterone, 3 alpha-hydroxy-5 alpha-dihydroprogesterone and 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone, are potent barbiturate-like ligands of the gamma-aminobutyric acid (GABA) receptor-chloride ion channel complex. At concentrations between 10(-7) and 10(-5)M both steroids inhibited binding of the convulsant t-butylbicyclophosphorothionate to the GABA-receptor complex and increased the binding of the benzodiazepine flunitrazepam; they also stimulated chloride uptake (as measured by uptake of 36Cl-) into isolated brain vesicles, and potentiated the inhibitory actions of GABA in cultured rat hippocampal and spinal cord neurons. These data may explain the ability of certain steroid hormones to rapidly alter neuronal excitability and may provide a mechanism for the anesthetic and hypnotic actions of naturally occurring and synthetic anesthetic steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Allo acts at nanomolar concentrations as an anesthetic, anxiolytic anticonvulsant by binding to GABA A receptors at sites distinct from those bound by GABA, benzodiazepines, and barbiturates, functioning as an allosteric modulator to open the channel and increase chloride flux (696 -699).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [696]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines
Tallman, J. F., Paul, S. M., Skolnick, P., & Gallager, D. W. (1980) · Science · doi:10.1126/science.6101294 · Cited by 862
Self-citationA patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine
Fenwick, E. M., Marty, A., & Neher, E. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014393 · Cited by 812
GABAergic modulation of benzodiazepine binding site sensitivity
TALLMAN, J. F., THOMAS, J. W., & GALLAGER, D. W. (1978) · Nature · doi:10.1038/274383a0 · Cited by 722
DRUG INTERACTIONS AT THE GABA RECEPTOR-IONOPHORE COMPLEX
Olsen, R. W. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.001333 · Cited by 695
Study, R. E., & Barker, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7180 · Cited by 561
Self-citationSquires, R. F., Casida, J. E., Richardson, M., & Saederup, E. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14273-9 · Cited by 551
New concepts on the mechanism of action of benzodiazepines
Costa, E., Guidotti, A., Mao, C. C., & Suria, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90501-9 · Cited by 536
Modulation of the GABA receptor complex by a steroid anaesthetic
Harrison, N. L., & Simmonds, M. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90299-3 · Cited by 499
Self-citationAnnual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Research works printed but not linked: 15
- ADAMS, P.R., ADVANCES IN PHYSIOLOGICAL SCIENCES 4: 135 (1981).
- BAULIEU, E.E., STEROID HORMONE REGU: 3 (1980).
- FELDMAN, S, INTEGRATIVE NEUROHUM: 173 (1983).
- HAEFELY, W, ANXIOLYTICS NEUROCHE: 113 (1983).
- HARRISON, N.L., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 15: 81 (1985).
- HOLZBAUER, M, J PHYSL LONDON 210: 123 (1970).
- KARAVOLAS, H.J., METABOLISM HORMONAL: 149 (1984).
- Leeb-Lundberg, F., Proceedings of the National Academy of Sciences of the United States of America 77: 7468 (1980).
- MAJEWSKA, M.D., MOL PHARM 25: 353 (1984).
- MCEWEN, B.S., ADRENAL ACTIONS BRAI: 1 (1982).
- RIKKER, J, ADRENAL ACTIONS BRAI: 69 (1982).
- Study, R. E., Proceedings of the National Academy of Sciences of the United States of America 78: 7180 (1981).
- STUMPF, W.E., STEROID HORMONE REGU: 41 (1980).
- TRIFILETTI, R.R., EUR J PHARMACOL 106: 441 (1985).
- Cottrell G. L. Journal of Physiology in press.
Cited by
Items 701–800 of 1,008
Liu, B., Wang, G., Gao, D., Gao, F., Zhao, B., Qiao, M., Yang, H., Yu, Y., Ren, F., Yang, P., et al. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.10.020 · Cited by 63
“ALLO and pregnenolone, neuroactive derivatives of progesterone, have been found to be positive modulators of the GABAA receptor (Majewska et al., 1986).”
BackgroundAnxiety disorders in pregnancy
Vythilingum, B. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0053-y · Cited by 71
Pierucci‐Lagha, A., Covault, J., Feinn, R., Khisti, R. T., Morrow, A. L., Marx, C. E., Shampine, L. J., & Kranzler, H. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0231-0 · Cited by 65
“…ALLO), 3α, 21-dihydroxy-5α-pregnan-20-one (THDOC), and 3α-hydroxy-5β-pregnan-20-one (pregnanolone) act as potent positive allosteric modulators at the GABAA receptor (Holzbauer et al. 1985; Majewska 1992; Majewska et al. 1986; Morrow et al. 1987; Schumacher and McEwen 1989; Paul and Purdy 1992).”
BackgroundRole of GABA in cerebral cortex
Krnjevic, K. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-5-439 · Cited by 61
Uzunova, V., Ceci, M., Kohler, C., Uzunov, D. P., & Wrynn, A. S. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02577-0 · Cited by 67
Structure and function of 3α-hydroxysteroid dehydrogenase
Penning, T. M., Bennett, M. J., Smith-Hoog, S., Schlegel, B. P., Jez, J. M., & Lewis, M. (1997) · Steroids · doi:10.1016/s0039-128x(96)00167-5 · Cited by 62
Possible role of Ca2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta
Perusquı́a, M., & Villalón, C. M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00161-2 · Cited by 62
Reversal of Behavioral Effects of Pentylenetetrazol by the Neuroactive Steroid Ganaxolone
Beekman, M., Ungard, J. T., Ga̧sior, M., Carter, R. B., Dijkstra, D., Goldberg, S. R., & Witkin, J. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37308-2 · Cited by 66
Mammalian 3α-hydroxysteroid dehydrogenases
Penning, T. M., Pawlowski, J. E., Schlegel, B. P., Jez, J. M., Lin, H.-K., Hoog, S. S., Bennett, M. J., & Lewis, M. (1996) · Steroids · doi:10.1016/s0039-128x(96)00093-1 · Cited by 64
Kleingoor, C., Ewert, M., Blankenfeld, G. V., SEEBURG, P. H., & Kettenmann, H. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90389-b · Cited by 62
Pleiotropic Signaling Pathways in Rapid, Nongenomic Action of Glucocorticoid
Chen, Y.-Z., & Qiu, J. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0163 · Cited by 62
Paris, J. J., Brunton, P. J., Russell, J. A., & Frye, C. A. (2011) · Stress · doi:10.3109/10253890.2011.628719 · Cited by 59
“1986) and instead acts via γ-aminobutyric acid A (GABAA) receptors (Majewska et al. 1986).”
Expression of membrane progestin receptors in zebrafish (Danio rerio) oocytes, testis and pituitary
Hanna, R. N., & Zhu, Y. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.10.006 · Cited by 61
“Progestinmediated rapid release of gonadotropin and subsequent downstream signaling has been demonstrated in the pituitary, but the specific receptors mediating these actions have not been identified (Majewska et al., 1986; Calogero et al., 1998; Sim et al., 2001).”
BackgroundCarver, C. M., Wu, X. Y., Gangisetty, O., & Reddy, D. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0596-14.2014 · Cited by 65
“AP concentrations 1 M were not tested because of the ability of neurosteroids to directly activate GABAARs at higher concentrations via a separate binding domain (Majewska et al., 1986; Wohlfarth et al., 2002; Reddy and Rogawski, 2002).”
BackgroundPoletti, A., & Martini, L. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00150-2 · Cited by 66
Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome
Lombardi, I., Luisi, S., Quirici, B., Monteleone, P., Bernardi, F., Liut, M., Casarosa, E., Palumbo, M., Petraglia, F., & Genazzani, A. R. (2004) · Gynecological Endocrinology · doi:10.1080/09513590310001652955 · Cited by 60
Kask, K., Gulinello, M. E., Bäckström, T. C., Geyer, M. A., & Poromaa, I. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301599 · Cited by 64
“Acutely, allopregnanolone enhances inhibitory neurotransmission (Majewska et al, 1986), thus exerting anxiolytic (Akwa et al, 1999; Bitran et al, 1991, 1993), sedative (Lancel et al, 1997; Timby et al, 2006), and antiepileptic effects (Landgren et al, 1998).”
Estrogen acutely inhibits ion transport by isolated stria vascularis
Lee, J. H., & Marcus, D. C. (2001) · Hearing Research · doi:10.1016/s0378-5955(01)00316-1 · Cited by 61
“First, there is a possibility that E2 is metabolized by strial cells to a daughter compound that has a much higher a⁄nity than E2. A similar situation was reported for stimulation by progesterone of Q-aminobutyric acid-activated chloride channels ( Majewska et al., 1986 ) and of vitamin D-mediated osteoblast calcium c…”
BackgroundLordosis facilitation in estrogen primed rats by intrabrain injection of pregnanes
Beyer, C., González‐Mariscal, G., Eguibar, J. R., & Gómora‐Arrati, P. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90405-4 · Cited by 62
Flumazenil blocks the anxiolytic action of allopregnanolone
Fernández‐Guasti, A., & Picazo, O. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00311-8 · Cited by 61
Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid
Zaman, S. H., Shingai, R., Harvey, R. J., Darlison, M. G., & Barnard, E. A. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90106-6 · Cited by 72
An Update on Mood and Anxiety Disorders During Pregnancy and the Postpartum Period
Altshuler, L. L., Hendrick, V., & Cohen, L. S. (2000) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v02n0604 · Cited by 62
A new meaning for “Gin & Tonic”: tonic inhibition as the target for ethanol action in the brain
Módy, I., Glykys, J. C., & Wei, W. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.03.009 · Cited by 64
“The most potent positive endogenous modulators of GABAA receptor function are the 3α-hydroxy ring A-reduced pregnane steroids, that have sedative-hypnotic, anticonvulsant, and anxiolytic effects (Majewska et al., 1986;Belelli and Lambert, 2005).”
BackgroundBreier, A. F., & Buchanan, R. W. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90563-5 · Cited by 60
Hsu, F.-C., & Smith, S. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00195.2002 · Cited by 58
“3 ,5 -THP is a potent positive modulator of GABAR at physiological concentrations (10–100 nM), where it acts in a barbiturate-like fashion to prolong the open time of the GABA-gated Cl channel (Callachan et al. 1987; Majewska et al. 1986; Twyman and Macdonald 1992), an effect that would enhance GABAergic inhibition at…”
BackgroundCzłonkowska, A. I., Krząścik, P., Sienkiewicz‐Jarosz, H., Siemiątkowski, M., Szyndler, J., Bidziński, A., & Płaźnik, A. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00369-5 · Cited by 63
Increased neurosteroids synthesis after brain and spinal cord injury in rats
di Michele, F., Lekieffre, D., Pasini, A., Bernardi, G., Bénavidès, J., & Romeo, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00965-4 · Cited by 60
Micronized progesterone: clinical indications and comparison with current treatments
Fitzpatrick, L. A., & Good, A. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00272-1 · Cited by 60
Türkmen, Ş., Lundgren, P., Birzniece, V., Zingmark, E., Bäckström, T. C., & Johansson, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03610.x · Cited by 62
“, 1986), increasing the frequency and duration of channel opening (Majewska et al., 1986; MacDonald & Twyman, 1992; Paul & Purdy, 1992).”
BackgroundDifferential Modulation of the γ-Aminobutyric Acid Type C Receptor by Neuroactive Steroids
Morris, K. D. W., Moorefield, C. N., & Αmin, J. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12537-0 · Cited by 60
Frye, C. A., & DeBold, J. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91653-a · Cited by 60
Regionaland Interspecies Differences in Brain Progesterone Metabolism
Korneyev, A., Guidotti, A., & Costa, E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07440.x · Cited by 60
Barsony, J., & Marx, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1223 · Cited by 61
Neurosteroids as neuromodulators in the treatment of anxiety disorders
Longone, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00055 · Cited by 55
“While 3α, 5α-THP binds to GABAA receptors thereby increasing the time and frequency of the opening of the Clchannel (Majewska et al., 1986), pregnenolone sulfate (PREGS) has been described as both a positive NMDA receptor modulator (Figure 3B; Kussius et al., 2009) and negative GABAA receptor modulator (Mtchedlishvili…”
BackgroundNeurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor
Strömberg, J., Haage, D., Taube, M., Bäckström, T. C., & Lundgren, P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.031 · Cited by 59
Nahoum, V., Gangloff, A., Legrand, P., Zhu, D.-W., Cantin, L., Zhorov, B. S., Luu-The, V., Labrie, F., Breton, R., & Lin, S.-X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105610200 · Cited by 59
Kurata, K., Takebayashi, M., Kagaya, A., Morinobu, S., & Yamawaki, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00880-9 · Cited by 59
Frye, C. A., & Rhodes, M. E. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01494.x · Cited by 56
The oxytocin receptor: a target for steroid hormones
Schumacher, M., Coirini, H., Johnson, A. E., Flanagan‐Cato, L. M., Frankfurt, M., Pfaff, D. W., & McEwen, B. S. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90192-b · Cited by 58
Beyer, C., González‐Flores, O., & González‐Mariscal, G. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)00141-5 · Cited by 58
Korz, V., & Frey, J. U. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0910-05.2005 · Cited by 58
“, 1996), probably by interaction with different neurotransmitter receptors (Majewska et al., 1986; McEwen et al., 1990; Schumacher, 1990), a rapid nongenomic effect of MR may also play a role in LTP modulation.”
BackgroundOlsen, R. W., Sapp, D. W., Bureau, M., TURNER, D. M., & Kokka, N. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb33838.x · Cited by 58
Frye, C. A., & Rhodes, M. E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.016 · Cited by 58
Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice
Meyer, J. H., & Gruol, D. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91546-6 · Cited by 63
The effects of general anaesthetics on gabaergic synaptic transmission
Keane, P. E., & Bizière, K. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90708-9 · Cited by 62
Xenobiotic Metabolism in Brain
Ravindranath, V., & Boyd, M. R. (1995) · Drug Metabolism Reviews · doi:10.3109/03602539508998330 · Cited by 58
Alteration in auditory function during the ovarian cycle
Al-Mana, D., Ćeranić, B., Djahanbakhch, O., & LUXON, L. M. (2010) · Hearing Research · doi:10.1016/j.heares.2010.05.007 · Cited by 61
Mineralocorticoid receptor ligands: Biochemical, pharmacological, and clinical aspects
Sutanto, W., & de Kloet, E. R. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110604 · Cited by 63
Neuroendocrine pathways underlying risk and resilience to PTSD in women
Ravi, M., Stevens, J. S., & Michopoulos, V. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100790 · Cited by 59
Rapid anxiolytic activity of progesterone and pregnanolone in male rats
Gómez, C., Saldívar-González, A., Delgado, G., & Rodriguez, R. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00722-0 · Cited by 63
Strömberg, J., Bäckström, T. C., & Lundgren, P. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04047.x · Cited by 60
“A receptor (Majewska et al., 1986; McEwen, 1991; Purdy et al., 1991; Reddy, 2003).”
BackgroundAction by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders
Wihlbäck, A., Poromaa, I. S., & Bäckström, T. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0185-2 · Cited by 59
“ALLO and pregnanolone have anxiolytic and anesthetic properties and were proved, as early as in the 1980s, to exert this action by enhancing gamma-aminobutyric acid (GABA)-stimulated chloride conductance in the rat brain (Harrison and Simmonds 1984; Majewska et al. 1986).”
BackgroundLiu, Q., Chang, Y. H., Schaffner, A. E., Smith, S. V., & Barker, J. L. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00942.2001 · Cited by 58
Self-citationExpression of Steroid Sulfatase during Embryogenesis
Compagnone, N. A., SALIDO, E. C., Shapiro, L. J., & Mellon, S. H. (1997) · Endocrinology · doi:10.1210/en.138.11.4768 · Cited by 57
Progesterone Protective Effects in Neurodegeneration and Neuroinflammation
Nicola, A. F. D., Deniselle, M. C. G., Garay, L. I., Meyer, M., Gargiulo-Monachelli, G. M., Guennoun, R., Schumacher, M., Carreras, M. C., & Poderoso, J. J. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12043 · Cited by 61
Botella, G. M., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Shen, K., Belfort, G. M., Loya, C. M., Ackley, M. A., Grossman, S. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00032 · Cited by 57
PRANDOTA, J. (2009) · Research in Autism · doi:10.1016/j.rasd.2009.09.011 · Cited by 59
Effect of corticosteroid hormones on electrical activity in rat hippocampus
Joëls, M., & de Kloet, E. R. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90170-a · Cited by 59
Potentiators of responses to activation of $gamma;-aminobutyric acid (GABAA) receptors
Simmonds, M. A., & Turner, J. P. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90071-2 · Cited by 58
Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons
Weaver, C. E., Wu, F., Gibbs, T. T., & Farb, D. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00640-4 · Cited by 60
GABAB receptor-mediated increase of neurosteroids by γ-hydroxybutyric acid
Barbaccia, M. L., Colombo, G., Affricano, D., Carai, M. A. M., Vacca, G., Melis, S., Purdy, R. H., & Gessa, G. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00026-6 · Cited by 56
Melcangi, R. C., Riva, M. A., Furnagalli, F., Magnaghi, V., Racagni, G., & Martini, L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01302-4 · Cited by 59
Porcu, P., O’Buckley, T. K., Alward, S. E., Song, S. C., Grant, K. A., de Wit, H., & Morrow, A. L. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01123.x · Cited by 55
“…5β-reduced metabolites of progesterone, deoxycorticosterone, dehydroepiandrosterone (DHEA) and testosterone (Frye et al., 1996; Kaminski et al., 2005; Majewska et al., 1986) induce GABAergic actions that result in anxiolytic, anticonvulsant, sedative/hypnotic and cognitive effects (Biggio and…”
Progesterone metabolism in adipose cells
Zhang, Y., Nadeau, M., Faucher, F., Lescelleur, O., Biron, S., Daris, M., Rhéaume, C., Luu-The, V., & Tchernof, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.034 · Cited by 55
Neurosteroid and neurotransmitter alterations in Parkinson’s disease
di Michele, F., Luchetti, S., Bernardi, G., Romeo, E., & Longone, P. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.03.001 · Cited by 60
Montagnese, S., Lauridsen, M. M., Vilstrup, H., Zarantonello, L., Lakner, G., Fitilev, S. B., Зупанец, И. А., Козлова, И. В., Bunkova, E., Tomasiewicz, K., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.012 · Cited by 57
Ethanol and neurosteroid interactions in the brain
Morrow, A. L., VanDoren, M. J., Fleming, R. L., & Penland, S. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46068-5 · Cited by 60
Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights
Mathias, J. R., Franklin, R. R., Quast, D. C., Fraga, N., Loftin, C. A., Yates, L., & Harrison, V. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00096-x · Cited by 55
GABA synthesis in Schwann cells is induced by the neuroactive steroid allopregnanolone
Magnaghi, V., Párducz, Á., Frasca, A., Ballabio, M., Procacci, P., Racagni, G., Bonanno, G., & Fumagalli, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06512.x · Cited by 58
Effects of acute progesterone administration upon responses to acute psychosocial stress in men.
Childs, E., Van Dam, N. T., & Wit, H. D. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0018060 · Cited by 52
Matsui, D., Sakari, M., Sato, T., Murayama, A., Takada, I., Kim, M.-S., Takeyama, K.-I., & Kato, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1387 · Cited by 58
Frye, C. A., & Vongher, J. M. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00731.x · Cited by 59
Identification of type 1 5α-reductase in myelin membranes of male and female rat brain
Poletti, A., Celotti, F., Rumio, C., Rabuffetti, M., & Martini, L. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04056-2 · Cited by 62
Hawkinson, J. E., Kimbrough, C. L., McCauley, L. D., Bolger, M. B., Lan, N. C., & Gee, K. W. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90082-5 · Cited by 55
Premenstrual Syndrome — Pathophysiologic Considerations
Mortola, J. F. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380409 · Cited by 55
The neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons
Moore, A. M., & Campbell, R. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.002 · Cited by 56
Frye, C. A., Koonce, C. J., & Walf, A. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00106 · Cited by 58
“…neuro(active)steroids, such as allopregnanolone, are known to have rapid effects, including those on neuronal excitability and synaptic function (Majewska et al., 1986; Morrow et al., 1987; Gee et al., 1995; Brot et al., 1997; Qiu and Lange, 2003; Weir et al., 2004; Lange, 2004; Belelli and…”
BackgroundReproductive hormonal changes and catamenial pattern in adolescent females with epilepsy
El‐Khayat, H. A., Soliman, N., Tomoum, H. Y., Omran, M. A., El‐Wakad, A. S., & Shatla, R. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01622.x · Cited by 56
“On the other hand, P metabolite allopregnanolone, often referred to a “neurosteroid,” is a powerful positive allosteric modulator of GABAA receptors (Majewska et al., 1986).”
BackgroundTemporal lobe epilepsy and the BDNF receptor, TrkB
McNamara, J. O., & Scharfman, H. E. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02832.x · Cited by 54
He, X., Węgiel, J., Yang, Y., Pullarkat, R. K., Schulz, H., & Yang, S. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.08.011 · Cited by 54
“17 -HSD10 is the human brain enzyme really capable of catalyzing the oxidation of allopregnanolone and 3 ,5 -THDOC, which are steroid modulators of GABA receptors (Majewska et al., 1986).”
Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications
Cai, H., Cao, T., Zhou, X., & Yao, J. K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00073 · Cited by 55
The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause
Kimball, A., Dichtel, L. E., Nyer, M., Mischoulon, D., Fisher, L. B., Cusin, C., Dording, C. M., Trinh, N., Yeung, A., Haines, M. S., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104512 · Cited by 54
Development of neuroactive steroids for the treatment of postpartum depression
Gunduz‐Bruce, H., Takahashi, K. U., & Huang, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13019 · Cited by 60
Estrogen Signaling in the Hypothalamus
Kelly, M. J., Qiu, J., & Rønnekleiv, O. K. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71005-0 · Cited by 60
Neuroactive steroids as modulators of depression and anxiety
Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.007 · Cited by 57
Neurosteroid Effects on GABAergic Synaptic Plasticity in Hippocampus
Hsu, F., Waldeck, R. F., Faber, D. S., & Smith, S. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00780.2002 · Cited by 55
“currents of hippocampal neurons (Majewska et al. 1986) by”
BackgroundInhibitory Effect of Sex Steroids on Guinea-Pig Airway Smooth Muscle Contractions
Perusquı́a, M., Hernández, R., Montaño, L. M., Villalón, C. M., & Campos, M. G. (1997) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(97)00029-7 · Cited by 54
Benzodiazepines in the Treatment of Alcoholism
Nutt, D. J., Adinoff, B. H., & Linnoila, M. (1989) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1678-5_15 · Cited by 61
Estradiol benzoate potentiates neuroactive steroids' effects on pain sensitivity
Frye, C. A., & Duncan, J. E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00194-8 · Cited by 57
Panic disorder during pregnancy
Cowley, D. S., & Roy-Byrne, P. P. (1989) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674828909016694 · Cited by 55
Chlormethiazole: neurochemical actions at the γ-aminobutyric acid receptor complex
Moody, E. J., & Skolnick, P. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90242-2 · Cited by 54
Concas, A., Mostallino, M. C., Perra, C., Lener, R., Roscetti, G., Barbaccia, M. L., Purdy, R. H., & Biggio, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15476.x · Cited by 53
Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study
Zaki, A., & Barrett‐Jolley, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704832 · Cited by 52
“Investigation of possible GABA receptor interactions with cortisol In many cases, steroids modulate neuronal activity by interaction with GABAA receptors (Majewska et al., 1986; Paul & Purdy, 1992).”
BackgroundSchweizer, E. E., CASE, W. G., España, F. G., Rickels, K., & Greenblatt, D. J. (1995) · Psychopharmacology · doi:10.1007/bf02246214 · Cited by 53
Social isolation‐induced increase in the sensitivity of rats to the steroidogenic effect of ethanol
Serra, M., Pisu, M. G., Floris, I., Cara, V., Purdy, R. H., & Biggio, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01680.x · Cited by 53
Criswell, H. E., Ming, Z., Griffith, B. L., & Breese, G. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041590 · Cited by 53
“As noted above, the neuroactive steroids reliably enhance GABA-gated currents in agreement with others (Majewska et al., 1986; Maitra and Reynolds, 1998; Criswell et al., 1999; Hsiao et al., 2001).”
Lière, P., Pianos, A., Eychenne, B., Cambourg, A., Bodin, K., Griffiths, W. J., Schumacher, M., Baulieu, É.-É., & Sjövall, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900162-jlr200 · Cited by 54
Bloch, G. J., Butler, P. C., Kohlert, J. G., & Bloch, D. A. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90068-q · Cited by 53
Peoples, R. W., & Weight, F. F. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17025.x · Cited by 53
Meczekalski, B., Tonetti, A., Monteleone, P., Bernardi, F., Luisi, S., Stomati, M., Luisi, M., Petraglia, F., & Genazzani, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420280 · Cited by 52
Metadata
- Authors
- Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1986-05-23
- Volume
- 232
- Issue
- 4753
- Pages
- 1004-1007
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2083447043
- Semantic Scholar
- 55b4fcd5a62357b63d7cb0aaf4869cfd9cf57ad2
- Cited by
- 2,225
- References
- 45
- Citations by year
- 2026: 15 · 2025: 31 · 2024: 26 · 2023: 28 · 2022: 37 · 2021: 35 · 2020: 38 · 2019: 47 · 2018: 35 · 2017: 28 · 2016: 40 · 2015: 33 · 2014: 48 · 2013: 51 · 2012: 52
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- steroid hormone metabolites, GABA receptors, progesterone, deoxycorticosterone, t-butylbicyclophosphorothionate, flunitrazepam binding, chloride uptake, neuronal excitability, hippocampal neurons, spinal cord neurons
- MeSH terms
- Animals, Bridged Bicyclo Compounds, Binding, Competitive, Brain, Cells, Cultured, Chlorides, Desoxycorticosterone, 20-alpha-Dihydroprogesterone, Drug Synergism, Flunitrazepam, Hippocampus, Ion Channels, Progesterone, Receptors, GABA-A, Spinal Cord, Bridged Bicyclo Compounds, Heterocyclic, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.